352 related articles for article (PubMed ID: 16265692)
21. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
22. Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.
Nifli AP; Notas G; Mamoulaki M; Niniraki M; Ampartzaki V; Theodoropoulos PA; Kopnitsky MJ; Castanas E
J Immunol Methods; 2006 Apr; 311(1-2):189-97. PubMed ID: 16554066
[TBL] [Abstract][Full Text] [Related]
23. Pattern on the antinuclear antibody-HEp-2 test is a critical parameter for discriminating antinuclear antibody-positive healthy individuals and patients with autoimmune rheumatic diseases.
Mariz HA; Sato EI; Barbosa SH; Rodrigues SH; Dellavance A; Andrade LE
Arthritis Rheum; 2011 Jan; 63(1):191-200. PubMed ID: 20954189
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance and frequency of cytoplasmic and nuclear dense fine speckled patterns observed in ANA-HEp-2.
Pazini AM; Fleck J; dos Santos RS; Beck ST
Rev Bras Reumatol; 2010; 50(6):655-60. PubMed ID: 21243306
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of Samples with DFS Staining Pattern Detected by Indirect Immunofluorescence Assay.
Togay A; Mutlu E; Ongut G; Mutlu D; Colak D; Gultekin M
Clin Lab; 2018 Mar; 64(3):393-397. PubMed ID: 29739116
[TBL] [Abstract][Full Text] [Related]
26. Recognition of the dense fine speckled (DFS) pattern remains challenging: results from an international internet-based survey.
Bentow C; Fritzler MJ; Mummert E; Mahler M
Auto Immun Highlights; 2016 Dec; 7(1):8. PubMed ID: 27395414
[TBL] [Abstract][Full Text] [Related]
27. Detection of antinuclear antibodies: comparative evaluation of enzyme immunoassay and indirect immunofluorescence methods.
Homburger HA; Cahen YD; Griffiths J; Jacob GL
Arch Pathol Lab Med; 1998 Nov; 122(11):993-9. PubMed ID: 9822128
[TBL] [Abstract][Full Text] [Related]
28. Can an ELISA replace immunofluorescence for the detection of anti-nuclear antibodies?--The routine use of anti-nuclear antibody screening ELISAs.
Sinclair D; Saas M; Williams D; Hart M; Goswami R
Clin Lab; 2007; 53(3-4):183-91. PubMed ID: 17447656
[TBL] [Abstract][Full Text] [Related]
29. Specific chemoluminescence and immunoasdorption tests for anti-DFS70 antibodies avoid false positive results by indirect immunofluorescence.
Bizzaro N; Tonutti E; Tampoia M; Infantino M; Cucchiaro F; Pesente F; Morozzi G; Fabris M; Villalta D;
Clin Chim Acta; 2015 Dec; 451(Pt B):271-7. PubMed ID: 26471835
[TBL] [Abstract][Full Text] [Related]
30. The Clinical Relevance of Anti-DFS70 Autoantibodies.
Conrad K; Röber N; Andrade LE; Mahler M
Clin Rev Allergy Immunol; 2017 Apr; 52(2):202-216. PubMed ID: 27350273
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of antinuclear antibodies by indirect immunofluorescence and line immunoassay methods': four years' data from Turkey.
Sener AG; Afsar I; Demirci M
APMIS; 2014 Dec; 122(12):1167-70. PubMed ID: 24735346
[TBL] [Abstract][Full Text] [Related]
32. The significance of dense fine speckled pattern in antinuclear antibody-associated rheumatic disease and coexisting autoantibodies: A propensity score-matched cohort study.
Cheng CF; Lan TY; Kao JH; Lu CH; Chang YC; Huang YM; Yang FJ; Chen JH; Lin YC; Chuang CA; Chang CH; Li KJ; Shen CY; Hsieh SC
Int J Rheum Dis; 2023 Sep; 26(9):1667-1675. PubMed ID: 37338084
[TBL] [Abstract][Full Text] [Related]
33. The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases.
Mahler M; Fritzler MJ
Clin Dev Immunol; 2012; 2012():494356. PubMed ID: 23304189
[TBL] [Abstract][Full Text] [Related]
34. [Investigation of the Clinical Significance of Anti-Dense Fine Speckled 70 (anti-DFS70) Autoantibody and Determination of Accompanying Pathologies].
Çetin Duran A; Barut K; Duran A; Eren Dağlar D
Mikrobiyol Bul; 2021 Jul; 55(3):415-425. PubMed ID: 34416806
[TBL] [Abstract][Full Text] [Related]
35. The choice of anti-LEDGF/DFS70 assay matters: a comparative study of six assays.
Troelnikov A; Hender L; Lester S; Gordon TP; Hughes T; Beroukas D
Pathology; 2022 Dec; 54(7):910-916. PubMed ID: 36241554
[TBL] [Abstract][Full Text] [Related]
36. New genetically engineered DFS70 knock-out HEp-2 cells enable rapid and specific recognition of anti-DFS70 antibodies.
Bizzaro N; Fabris M
Autoimmunity; 2018 Jun; 51(4):152-156. PubMed ID: 29732925
[TBL] [Abstract][Full Text] [Related]
37. Prevalence and serological profile of anti-DFS70 positive subjects from a routine ANA cohort.
Carbone T; Pafundi V; Tramontano G; Gilio M; Padula MC; Padula AA; D'Angelo S
Sci Rep; 2019 Feb; 9(1):2177. PubMed ID: 30778125
[TBL] [Abstract][Full Text] [Related]
38. Cost-effective detection of non-antidouble-stranded DNA antinuclear antibody specificities in daily clinical practice.
Vos PA; Bast EJ; Derksen RH
Rheumatology (Oxford); 2006 May; 45(5):629-35. PubMed ID: 16368728
[TBL] [Abstract][Full Text] [Related]
39. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
40. [The clinical characteristics of nuclear dense fine speckled pattern in 95 289 patients].
Luo YM; Wang R; Bai YN; Song N; Li MT; Zeng XF; Hu CJ
Zhonghua Nei Ke Za Zhi; 2022 Sep; 61(9):1044-1048. PubMed ID: 36008298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
